Lv1
2 积分 2025-10-29 加入
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study
3个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
3个月前
已完结
From niche to norm: a multiaction plan to close gaps and mainstream incremental hemodialysis
4个月前
已关闭
End stage renal disease has an early and continuous detrimental effect on regulatory T cells
4个月前
已完结
Premature aging in chronic kidney disease: Decoding senescence biomarkers and therapeutic opportunities
4个月前
已完结
IgA Nephropathy
4个月前
已完结
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies
4个月前
已关闭
皖公网安备34019202002308
